The Supreme Judicial Court has upheld a judge’s decision not to allow expert evidence on lost profits in a commercial dispute over optical coherence tomography (OCT) systems used to image human coronary arteries. Superior Court Judge Margaret R. Hinkle excluded opinion testimony from Roy Weinstein, plaintiff LightLab Imaging's expert economist, on the question of future lost...
Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces that leading experts in the use of optical technology in dermatology will be presenting the benefits of multi-beam OCT at the 24th Annual Education Week for Practical Dermatology and Venereology, known as Fortbildungswoche, in Munich, Germany, 19-25 July 2014. The conference session on ‘Evidence for OCT diagnostics’ will take place at 12:15-13:15, Forum 9, on Friday 25th July. The presentations include: Optical coherence tomography scientific fundamentals and applications, Dr. Martina Ulrich Optical coherence tomography for basal cell carcinoma, Prof. Dr ...
Avinger Inc., pioneer of the lumivascular approach for treating vascular disease announced today that Dr. John Pigott of Jobst Vascular Institute, Toledo, OH, enrolled the first patient in VISION. VISION is a global IDE clinical trial, approved by the FDA to evaluate Avinger’s PantherisTM catheter for the treatment of Peripheral Artery Disease (PAD). It is estimated that PAD affects 12 million people in the US alone. The PantherisTM system combines directional atherectomy capabilities with real-time intravascular visualization to remove plaque from blocked arteries. The minimally invasive catheter is designed to remove plaque, while avoiding the disruption of normal arterial ...
BiOM has named Dr. Charles Carignan as its next CEO, replacing Tim McCarthy, who left the company this past spring. Carignan is a 20-year medtech veteran who has held several key positions in the medical device industry, including most recently at NinePoint Medical, where he was the founder and CEO. In addition, Carignan has served as executive vice president and chief medical officer of Novasys Medical and held the same role at Boston Scientific (NYSE: BSX ). He was also the vice president of clinical research and medical affairs at Conceptus (NSDQ: CPTS ), where he oversaw the clinical development of the ...
HAAG-STREIT SURGICAL is pleased to introduce the world‘s first intraoperative OCT system, developed by OPMedT. An OCT camera is integrated into the high class operating microscope HS Hi-R NEO 900A NIR and its mounting system. OCT scans of the eye’s anterior and posterior segments are performed live during surgery, thus increasing the patient’s safety and improving quality control mechanisms for the surgeon. Discover more details than with a standard surgical microscope and enhance your performance! To see product brochure click HERE.
HAAG-STREIT SURGICAL's integrated iOCT system has been developed for intraoperative optical coherence tomography (iOCT™). It is non-invasive, and permits contact-free imaging for imaging structures and layers within the tissue. The iOCT's advantages find confirmation again and again among users and industry professionals: "When making corneal incisions, the iOCT shows you perfectly how the cornea is cleaved. This feedback allows you to adapt your technique to make a more water-tight incision. You can react to unexpected incidents immediately and avoid further complications.“, states Professor Peter Stalmans from the University of Leuven, Belgium. Professor Peter Stalmans from the University of ...
The all-new, 7000 square foot facility at 4905 Central Ave., Ste. 200 houses the company’s operations, R&D and manufacturing departments, Mirrorcle Technologies, Inc. (MTI) announced today. The move to the new, larger headquarters of the leading manufacturer of gimbal-less microelectromechanical system (MEMS) mirrors was prompted by the significant growth in 2013, by the subsequently expanding engineering and manufacturing teams, and by the continuously increasing customer demand. Steadily rising production volumes and quality operations requirements made it apparent that a move to a larger location was needed. At the same time, this move was also an opportunity to implement ...
Optores introduces the worlds first swept laser source with a sweep rate of up to 1.5 MHz for tomorrow's optical coherence tomography systems. The Optores swept source is based on all-fiber Fourier-domain mode-locked (FDML) laser technology. Designed for record speed, the Optores swept laser also features long coherence lengths and very high output powers beyond 80 mW. Three configuration variants are available to match your requirements.
Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, has commenced a clinical study to investigate the use of OCT to diagnose basal cell carcinoma in collaboration with the Melanoma Institute of Australia using Michelson’s Diagnostics VivoSight system. The study, run by Dr Pascale Guitera FACD PhD, will evaluate VivoSight’s ability to triage lesions which are superficial enough to be treated non-invasively and monitor the success, or otherwise, of non-invasive therapies. The study is designed to determine the potential to change clinical practice towards more non-invasive treatments of basal cell carcinoma ...
In his letter to shareholders, Monz also highlighted the recent introduction of the first ophthalmic surgery microscope to feature an integrated optical coherence tomography (OCT) camera as evidence of the company’s ongoing innovation. “The unique combination of two established Zeiss gold standards means we can now offer surgeons more comprehensive visualization during surgery, which enables better treatment results,” Monz wrote. Fierce competition in diagnostics Though growing fast, the surgical ophthalmology business unit remains Meditec’s smallest, accounting for €73.4 million of sales in the six months to the end of March. Multifocal and premium toric lenses developed recently ...
For production of fiber-based systems for OCT and more, also to be sales and support center for Canada. Now in Canada: Alex Cable Founder & President Thorlabs. Thorlabs , headquartered in Newton, NJ, USA, has announced that it has added a new R&D and manufacturing site to its global operations. Based in Montreal, Thorlabs Canada ULC will focus on the development and production of a range of innovative passive fiber-based optical components. The opening of the Canadian operation expands the company's geographical footprint, which now includes 13 manufacturing entities in nine countries over four continents. The Montreal team, currently four ...
According to a new report by iData Research ( http://www.idataresearch.com ), the leading global authority in medical device and pharmaceutical market research, the European diagnostic and interventional ophthalmic device market is expected to exceed €700 million by 2020. There are two main drivers fueling this market, technological innovation and the increasingly aging population that are affected with ocular diseases. As the population ages, the prevalence of ocular diseases such as cataracts and glaucoma increases. In addition, refractive problems such as myopia, hyperopia and astigmatism are more likely to occur in older people. These factors drive demand for specialized ophthalmic ...
Fujikura Europe, one of the world's leading manufacturers of fibre optic cables and equipment, has used 25 years of experience in the speciality splicing sector to enhance its technologies and products, including the LAZERMaster™ and ARCMaster® series, for use in the biomedical and research industries. Fujikura’s advanced splicing technology includes high-end CO₂ laser heating systems, to enable cleaner splicing with no contamination, no electrodes for low maintenance costs and little or no instability at all. Alongside the new products Fujikura will also be providing engineering and optimisation services in specialty splicing for fibre preparation applications. These include custom ...
Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces that Chief Executive Officer, Jon Holmes, will be presenting an overview of the Company at the 6 th Annual International Medtech Partnering Conference, EuroMedtech™ 2014, in Linz, Austria, 7-8 May 2014. EuroMedtech is Europe's leading medical technology partnering conference, providing collaboration opportunities to medtech decision makers and investors. The conference provides a platform for innovative companies interested in partnering their technologies or products, initiating strategic alliances, or tapping into the international financing network. In addition, early stage projects and small entrepreneurial ...
Voxeleron introduces Orion, advanced optical coherence tomography (OCT) analysis software. Orion is fully-automated soft-ware, rapidly and accurately segmenting seven retinal layers in OCT images. The limited functionality of existing OCT analysis tools has meant that only two or three retinal layers are analyzed, despite the overwhelming evidence for the clinical importance of the inner retinal layers in disease detection and prognosis. Orion address-es exactly this technology gap, providing researchers much needed biomarkers for the early detection and prognosis of ophthalmic and neurological diseases. Orion is device independent, processing data from different OCT vendors. Orion will be featured in two posters ...
The Cardiovascular Division participates in segments of the vascular and structural heart markets. Fractional Flow Reserve (FFR) and Optical Coherence Tomography (OCT) are two emerging technologies, which provide market opportunities, like the case of the ILUMIEN. This one is a platform that combines Fractional Flow Reserve (FFR) for measuring intra-arterial pressure with intravascular Optical Coherence Tomography (OCT) for a visual look inside arteries
Bioptigen Inc. today unveiled the Envisu IntraSurgical OCT for real-time imaging during ophthalmic surgical procedures. Key attributes of the Envisu IntraSurgical OCT include a wide, flat scan for accurate structural reproduction, and focal controls that operate independently of the microscope. These innovations will provide the surgeon with maximal versatility to assess surface and sub-surface tissue structures during surgical manipulations. Bioptigen’s Envisu IntraSurgical OCT is modularly designed for compatibility with new and existing operating microscopes to extend the power of OCT to surgical ophthalmology. "This advance brings surgeons one step closer to realizing the full value of intraoperative OCT", said ...
UK-headquartered Gooch and Housego (G&H) has won £0.8 million in government support via the UK’s Regional Growth Fund (RGF). The company, which says it will use the grant from the Department for Business, Innovation and Skills (BIS) to boost investment in its new systems technology business unit in Torbay, was one of 37 companies selected for RGF support in the fifth round of the competitive fund . In total, the RGF is expected to hand out £3.2 billion to UK businesses over seven years. “The objective is to build a multi-disciplinary team with expertise in mechanical, electronic ...
Bioptigen announced today the availability of EnFace TM color fundus technology delivering image-guided SDOCT into a single, compact, handheld scan head. The new color fundus system provides multiple, integrated modalities into each of Bioptigen’s Envisu TM preclinical SDOCT systems, producing brilliant, color fundus images captured simultaneously with OCT images. The new color image-guided OCT also complements Bioptigen’s volumetric OCT image visualization, and dynamic 3D tissue flattening capabilities to create a powerful, comprehensive suite of tools designed to meet the exacting needs of the ophthalmic research community. Bioptigen's new Envisu SDOCT scan head featuring integrated color fundus camera ...
St. Jude Medical, Inc . ( STJ ), a global medical device company, was recognized by Novation as the 2013 Innovative Technology Supplier of the Year. Novation members selected the St Jude Medical ILUMIEN™ PCI Optimization System based on their experience using the technology to deliver improved patient outcomes. Novation works with its more than 100,000 members and affiliates to identify innovative technology that improves patient care or reduces the risk of harm to patients or providers, while simultaneously raising the standard of patient care and safety. “Novation’s goals of improving patient outcomes through innovative technology align with our mission at ...
Imalux Corporation has announced that it has ceased operations due to various challenges to become a profitable on-going business. Imalux Corporation was one of the earliest OCT startup companies and received its first seed funding in 2000. Imalux opened operations in Cleveland Ohio with a strong technology connection to the Institute of Applied Physics in Russia. With the visionary leadership of Paul Amazeen and Felix Feldchtein Imalux developed the Niris product line that offered unique endoscopy imaging capabilities. Niris systems were delivered to customer's worldwide offering physicians the ability to identify structural changes in tissues, guide surgical interventions and ...
NIDEK, Inc. a global leader in the design, manufacturing, and distribution of ophthalmic equipment, is pleased to announce FDA clearance of the RS-3000 Advance . This premier OCT system incorporating Scanning Laser Ophthalmoscope is designed for comprehensive evaluation of the retina and choroid. The RS-3000 Advance provides exquisite detail of the retinal and choroidal microstructures to assist in clinical diagnosis. Features include the choroidal mode, which allows detailed evaluation of the choroid. A wide area scan of 9 mm x 9 mm ensures excellent overall coverage of the retinal structures. Microsaccades and other involuntary eye movements are compensated by the Tracing ...
Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, announces positive top line results from the successfully completed multi-centre, prospective clinical trial for the diagnosis of basal cell carcinoma using VivoSight OCT. In the study, over 250 patients with clinically suspicious lesions for basal cell carcinoma were scanned at six centres in Germany. In each case, diagnosis using VivoSight OCT was compared with standard clinical diagnosis with and without dermoscopy. All results were verified by the gold standard of biopsy and histological analysis. Papers by Professor Dr. med. Julia Welzel, Dr. med. Martina ...
NinePoint Medical, Inc. , an emerging leader in the development of medical devices for advanced optical imaging, today announced it has completed a $34 million Series B financing led by Corning Incorporated (NYSE: GLW), along with founding investors Third Rock Ventures and Prospect Venture Partners. The company also announced the addition of three new members to its board of directors: Curt Weinstein from Corning, and independent directors Tom Miller and Mark Stautberg. Proceeds from the financing will support the ongoing commercial launch of the NvisionVLE Imaging System in the U.S., as well as development of the company’s expanded product ...
